Skip to content
10-Q

Quarterly Report

BIOSYNERGY INC

0000715812-19-000024

← back to feed
Filed
Sep 13, 2019 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2019 · Jul 31, 2019 14.94M sh
Stockholders Equity Q1 2019 · Jul 31, 2019 $1.7M
Stockholders Equity Q1 2019 · Apr 30, 2019 $1.69M
Current Liabilities Q1 2019 · Jul 31, 2019 $125.28K
Current Liabilities Q1 2019 · Apr 30, 2019 $156.29K
Current Assets Q1 2019 · Jul 31, 2019 $1.65M
Current Assets Q1 2019 · Apr 30, 2019 $1.65M
Total Assets Q1 2019 · Jul 31, 2019 $1.85M
Total Assets Q1 2019 · Apr 30, 2019 $1.87M
Revenue Q1 2019 · Jul 31, 2019 $316.78K
Revenue Q1 2019 · Jul 31, 2018 $317.83K
Operating Cash Flow Q1 2019 · Jul 31, 2018 $23.22K
Cash And Equivalents Q1 2019 · Jul 31, 2018 $1.16M
Cash And Equivalents Q1 2019 · Apr 30, 2018 $1.14M
Sga Expense Q1 2019 · Jul 31, 2018 $117.34K
Rd Expense Q1 2019 · Jul 31, 2018 $36.92K
Net Income Q1 2019 · Jul 31, 2018 $10.38K
Operating Income Q1 2019 · Jul 31, 2018 $13.95K
Gross Profit Q1 2019 · Jul 31, 2018 $213.92K